JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M708933200 on April 1, 2008

J. Biol. Chem., Vol. 283, Issue 23, 15807-15815, June 6, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
283/23/15807    most recent
M708933200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Lin, M.-T.
Right arrow Articles by Kuo, M.-L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, M.-T.
Right arrow Articles by Kuo, M.-L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Involvement of Hypoxia-inducing Factor-1{alpha}-dependent Plasminogen Activator Inhibitor-1 Up-regulation in Cyr61/CCN1-induced Gastric Cancer Cell Invasion*Formula

Ming-Tsan Lin{ddagger}§, I-Hsin Kuo, Cheng-Chi Chang, Chia-Yu Chu||, Hsing-Yu Chen, Been-Ren Lin§, Munisamy Sureshbabu, Hou-Jung Shih, and Min-Liang Kuo**1

From the Departments of {ddagger}Primary Care Medicine, §Surgery, and ||Dermatology, the Laboratory of Molecular and Cellular Toxicology, and the **Institute of Toxicology, Angiogenesis Research Center, National Taiwan University Hospital, No. 1, Section 1, Jen-Ai Road, Taipei 100, Taiwan

Cysteine-rich 61 (Cyr61/CCN1), one of the members of CCN family, has been implicated in the progression of human malignancies. Previously, our studies have demonstrated that Cyr61/CCN1 has a role in promoting gastric cancer cell invasion, but the mechanism is not clear yet. Here, we found that hypoxia-inducing factor-1{alpha} (HIF-1{alpha}) protein, but not mRNA, expression was significantly elevated in gastric cancer cells overexpressing Cyr61. Supportively, a profound reduction of endogenous HIF-1{alpha} protein was noted in one highly invasive cell line, TSGH, when transfected with antisense Cyr61. By comparison, the induction kinetics of HIF-1{alpha} protein by recombinant Cyr61 (rCyr61) was distinct from that of insulin-like growth factor-1 and CoCl2 treatment, both well known for induction of HIF-1{alpha}. Using cycloheximide and MG132, we demonstrated that the Cyr61-mediated HIF-1{alpha} up-regulation was through de novo protein synthesis, rather than increased protein stability. rCyr61 could also activate the PI3K/AKT/mTOR and ERK1/2 signaling pathways, both of which were essential for HIF-1{alpha} protein accumulation. Blockage of HIF-1{alpha} activity in Cyr61-expressing cells by transfecting with a dominant negative (DN)-HIF-1{alpha} strongly inhibited their invasion ability, suggesting that elevation in HIF-1{alpha} protein is vital for Cyr61-mediated gastric cancer cell invasion. In addition, several HIF-1{alpha}-regulated invasiveness genes were examined, and we found that only plasminogen activator inhibitor-1 (PAI-1) showed a significant increase in mRNA and protein levels in cells overexpressing Cyr61. Treatment with PAI-1-specific antisense oligonucleotides or function-neutralizing antibodies abolished the invasion ability of the Cyr61-overexpressing cells. Transfection with dominant negative-HIF-1{alpha} to block HIF-1{alpha} activity also effectively reduced the elevated PAI-1 level. In conclusion, our data provide a detailed mechanism by which Cyr61 promoted gastric cancer cell invasive ability via an HIF-1{alpha}-dependent up-regulation of PAI-1.


Received for publication, October 30, 2007 , and in revised form, March 28, 2008.

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1 and S2 and additional text.

1 To whom correspondence should be addressed. Tel.: 886-2-2312-3456-8607; Fax: 886-2-2341-0217; E-mail: kuominliang{at}ntu.edu.tw.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.